Canada Life’s Meridian Bioscience Inc VIVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-54,697
Closed -$1.82M 2351
2022
Q4
$1.82M Buy
54,697
+543
+1% +$17.5K ﹤0.01% 1275
2022
Q3
$1.71M Buy
54,154
+11,059
+26% +$358K ﹤0.01% 1247
2022
Q2
$1.31M Buy
43,095
+5,806
+16% +$157K ﹤0.01% 1367
2022
Q1
$994K Sell
37,289
-802
-2% -$19.1K ﹤0.01% 1527
2021
Q4
$776K Hold
38,091
﹤0.01% 1602
2021
Q3
$739K Hold
38,091
﹤0.01% 1629
2021
Q2
$844K Buy
38,091
+35
+0.1% +$742 ﹤0.01% 1592
2021
Q1
$998K Sell
38,056
-3,658
-9% -$87K ﹤0.01% 1525
2020
Q4
$780K Sell
41,714
-6,793
-14% -$127K ﹤0.01% 1610
2020
Q3
$823K Sell
48,507
-4,664
-9% -$90.6K ﹤0.01% 1490
2020
Q2
$1.24M Buy
53,171
+279
+0.5% +$4.04K ﹤0.01% 1325
2020
Q1
$441K Hold
52,892
﹤0.01% 1637
2019
Q4
$512K Buy
+52,892
New +$497K ﹤0.01% 1706
2019
Q3
Sell
-56,124
Closed -$666K 2486
2019
Q2
$666K Sell
56,124
-929
-2% -$11.2K ﹤0.01% 1687
2019
Q1
$1M Hold
57,053
﹤0.01% 1381
2018
Q4
$915K Sell
57,053
-830
-1% -$14.2K ﹤0.01% 1431
2018
Q3
$859K Buy
57,883
+58
+0.1% +$899 ﹤0.01% 1581
2018
Q2
$919K Sell
57,825
-16
-0% -$239 ﹤0.01% 1561
2018
Q1
$821K Buy
57,841
+1,482
+3% +$21.9K ﹤0.01% 1579
2017
Q4
$789K Sell
56,359
-4,929
-8% -$72.2K ﹤0.01% 1608
2017
Q3
$867K Hold
61,288
﹤0.01% 1561
2017
Q2
$962K Hold
61,288
﹤0.01% 1530
2017
Q1
$842K Buy
61,288
+3,690
+6% +$51.6K ﹤0.01% 1565
2016
Q4
$1.02M Hold
57,598
﹤0.01% 1474
2016
Q3
$1.11M Hold
57,598
﹤0.01% 1396
2016
Q2
$1.12M Buy
57,598
+51,473
+840% +$1.01M ﹤0.01% 1357
2016
Q1
$126K Hold
6,125
﹤0.01% 1626
2015
Q4
$126K Hold
6,125
﹤0.01% 1600
2015
Q3
$105K Hold
6,125
﹤0.01% 1666
2015
Q2
$114K Hold
6,125
﹤0.01% 1766
2015
Q1
$116K Hold
6,125
﹤0.01% 1709
2014
Q4
$101K Hold
6,125
﹤0.01% 1750
2014
Q3
$109K Buy
6,125
+4,652
+316% +$91.4K ﹤0.01% 1616
2014
Q2
$30K Hold
1,473
﹤0.01% 2150
2014
Q1
$32K Hold
1,473
﹤0.01% 2015
2013
Q4
$39K Buy
+1,473
New +$36.2K ﹤0.01% 1928

Other funds holding VIVO

Canada Life's VIVO Position: Q1 2023 in Review

Canada Life sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 54,697 shares — an estimated $1.82M sold.

Canada Life first reported a position in VIVO in Q4 2013 and held it in 36 quarters. The position peaked at $1.82M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Canada Life reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Canada Life sold 54,697 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.82M.
  • Canada Life first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 36 quarters.
  • Canada Life's Meridian Bioscience Inc position peaked at $1.82M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Canada Life's 13F filing for Q1 2023, filed 12 May 2023.